Xstrata shares suspended on LSE as part of Glencore merger
Xstrata's shares were suspended on the London Stock Exchange on Wednesday as part of its planned merger with Glencore.
Xstrata's shares were suspended on the London Stock Exchange on Wednesday as part of its planned merger with Glencore.
The mining group said the suspension was approved following an application to the UK Listing Authority ahead of its merger with Glencore, which is expected to become effective on May 2nd, subject to court proceedings.
The company's shares were also suspended on the SIX Swiss Exchange from 7:00am.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Xstrata is the world's fourth-largest producer of copper. It aims to increase output by more than 50% from 2011 levels by 2015, on the back up of projects like the $5.2bn Las Bambas mine ramp up.
A merger between the two producers would account for around 7.0% of global copper supply, which is expected to increase with mines in Australia, Peru and Chile.
RD
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
What does Reeves’s plan for growth mean for UK investors?
Rachel Reeves says she is going “further and faster” to kickstart the UK economy, but investors are unlikely to be persuaded
By Katie Williams Published
-
Will China thrive during the Year of the Snake - or will Trump’s tariffs bite?
As the Chinese lunar new year begins, investors will be wondering whether allocating to the world’s second-largest economy will “rattle” up some big returns, or whether Trump’s tariffs will take a “venomous bite” out of investment performance
By Ruth Emery Published